Lower serum interleukin‐22 and interleukin‐35 levels are associated with disease status in neuromyelitis optica spectrum disorders

AIMS: The exact pathogenesis of neuromyelitis optica spectrum disorder (NMOSD) remains unclear. A variety of cytokines are involved, but few studies have been performed to explore the novel roles of interleukin‐22 (IL‐22) and interleukin‐35 (IL‐35) in NMOSD. Therefore, this study was designed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hong, Han, Lu, Zhou, Yun‐Jia, Ding, Jie, Cai, Yu, Hong, Rong‐Hua, Hao, Yong, Zhu, De‐Sheng, Shen, Xia‐Feng, Guan, Yang‐Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978267/
https://www.ncbi.nlm.nih.gov/pubmed/31342670
http://dx.doi.org/10.1111/cns.13198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978267/
https://www.ncbi.nlm.nih.gov/pubmed/31342670
http://dx.doi.org/10.1111/cns.13198

Ejemplares similares